Torres-de la Roche Luz Angela, Steljes Isabell, Janni Wolfgang, Friedl Thomas W P, De Wilde Rudy Leon
Human Medicine, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
Gynecology, Pius-Hospital Oldenburg, Oldenburg, Germany.
Geburtshilfe Frauenheilkd. 2020 Jun;80(6):601-610. doi: 10.1055/a-1170-5004. Epub 2020 Jun 17.
Obesity is a well-established risk factor for postmenopausal hormone-receptor positive breast cancer. The relationship between premenopausal breast cancer intrinsic subtypes and obesity is not completely elucidated; therefore, this systematic review was conducted to give an overview about the existing evidence. This review followed the PRISMA Statement for Systematic Reviews and Meta-analyses. Full electronic search was conducted in PubMed and Orbis for articles published in English between January 2008 and June 2018. The literature search was performed in June 2018 using search strings that combined the Medical Subject Headings (MeSH terms) keywords and/or text words in any field were used: "body mass index" (BMI) OR obesity OR overweight AND premenopausal breast cancer. 391 articles were found to be eligible, of which ultimately 21 were included comprising a total of 55 580 breast cancer patients. 45% were case-control studies, 35% were single cohort studies, 15% were cohort studies, two were cross-sectional studies, one was a multicenter-study and one was a pooled analysis. The evidence shows a tendency for an increased risk for the more aggressive triple negative breast cancer subtype in obese premenopausal women and a decreased risk for less aggressive tumor subtypes such as the luminal A subtype. The evidence is limited by small sample sizes for triple negative and HER2-positive subtypes in severely obese patients. Higher BMI might influence aggressive tumor characteristics among premenopausal women and has divergent impacts on the risk of different breast cancer subtypes. Further research is needed to confirm these results and to evaluate potential pathophysiologic mechanisms for the relationship between obesity and aggressive premenopausal breast cancer subtypes.
肥胖是绝经后激素受体阳性乳腺癌公认的危险因素。绝经前乳腺癌内在亚型与肥胖之间的关系尚未完全阐明;因此,本系统评价旨在概述现有证据。本评价遵循系统评价和Meta分析的PRISMA声明。在PubMed和Orbis中进行全面电子检索,以查找2008年1月至2018年6月期间发表的英文文章。2018年6月进行文献检索,使用的检索词组合了医学主题词(MeSH词)关键词和/或任何字段中的文本词:“体重指数”(BMI)或肥胖或超重以及绝经前乳腺癌。发现391篇文章符合条件,最终纳入21篇,共包括55580例乳腺癌患者。45%为病例对照研究,35%为单队列研究,15%为队列研究,2篇为横断面研究,1篇为多中心研究,1篇为汇总分析。证据表明,肥胖的绝经前女性中侵袭性更强的三阴性乳腺癌亚型风险增加,而侵袭性较弱的肿瘤亚型如腔面A型风险降低。证据因严重肥胖患者中三阴性和HER2阳性亚型的样本量较小而受到限制。较高的BMI可能会影响绝经前女性的侵袭性肿瘤特征,并且对不同乳腺癌亚型的风险有不同影响。需要进一步研究来证实这些结果,并评估肥胖与侵袭性绝经前乳腺癌亚型之间关系的潜在病理生理机制。